Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Putative correlates of protection against shigellosis assessing immunomarkers across responses to S. sonnei investigati…
Conti V; Rossi O; Clarkson KA; Mancini F; Nakakana UN; Sarakinou E; Callegaro A; Ferruzzi P; Acquaviva A; Arora AK; Marchetti E; Necchi F; Frenck RW; Martin LB; Kaminski RW; Podda A; Micoli F.
NPJ Vaccines
(Unknown)
Published: 2024
MVA-based vaccines are protective against lethal eastern equine encephalitis virus aerosol challenge in cynomolgus maca…
Beddingfield BJ; Plante KS; Plante JA; Weaver SC; Bose S; Krzykwa C; Chirichella N; Redmann RK; Seiler SZ; Dufour J; Blair RV; Endt K; Volkmann A; Maness NJ; Roy CJ.
NPJ Vaccines
(Unknown)
Published: 2024
Durable cross-protective neutralizing antibody responses elicited by lipid nanoparticle-formulated SARS-CoV-2 mRNA vacc…
Bae KH; Shunmuganathan B; Zhang L; Lim A; Gupta R; Wang Y; Chua BL; Wang Y; Gu Y; Qian X; Tan ISL; Purushotorman K; MacAry PA; White KP; Yang YY.
NPJ Vaccines
(Unknown)
Published: 2024
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL<sup>®</sup>…
Sharma H; Parekh S; Pujari P; Shewale S; Desai S; Kawade A; Lalwani S; Ravi MD; Kamath V; Mahopatra J; Kulkarni G; Tayade D; Ramanan PV; Uttam KG; Rawal L; Gawande A; Kumar NR; Tiple N; Vagha J; Thakkar P; Khandgave P; Deshmukh BJ; Agarwal A; Dogar V; Gautam M; Jaganathan KS; Kumar R; Sharma I; Gairola S.
NPJ Vaccines
(Unknown)
Published: 2024
Protective efficacy of a Zika purified inactivated virus vaccine candidate during pregnancy in marmosets.
Kim IJ; Gonzalez O; Tighe MP; Lanthier PA; Clark MJ; Travis KL; Low-Beer TC; Lanzer KG; Bernacki DT; Szaba FM; De La Barrera RA; Dussupt V; Mendez-Rivera L; Krebs SJ; Ross CN; Mdaki SD; Brasky KM; Layne-Colon D; Tardif SD; Thomas SJ; Modjarrad K; Blackman MA; Patterson JL.
NPJ Vaccines
(Unknown)
Published: 2024
Zika purified inactivated virus (ZPIV) vaccine reduced vertical transmission in pregnant immunocompetent mice.
Kim IJ; Tighe MP; Lanthier PA; Clark MJ; De La Barrera RA; Dussupt V; Mendez-Rivera L; Krebs SJ; Travis KL; Low-Beer TC; Cookenham TS; Lanzer KG; Bernacki DT; Szaba FM; Schneck AA; Ward J; Thomas SJ; Modjarrad K; Blackman MA.
NPJ Vaccines
(Unknown)
Published: 2024
SARS-CoV-2 vaccination may mitigate dysregulation of IL-1/IL-18 and gastrointestinal symptoms of the post-COVID-19 cond…
Fischer C; Willscher E; Paschold L; Gottschick C; Klee B; Diexer S; Bosurgi L; Dutzmann J; Sedding D; Frese T; Girndt M; Hoell JI; Gekle M; Addo MM; Schulze Zur Wiesch J; Mikolajczyk R; Binder M; Schultheiß C.
NPJ Vaccines
(Unknown)
Published: 2024
Beneficial effect of temporary methotrexate interruption on B and T cell responses upon SARS-CoV-2 vaccination in patie…
Martínez-Fleta P; Vicente-Rabaneda EF; Triguero-Martínez A; Roy-Vallejo E; Uriarte-Ecenarro M; Gutiérrez-Rodríguez F; Quiroga-Colina P; Romero-Robles A; Montes N; García-Castañeda N; Mejía-Abril GP; García-Vadillo JA; Llorente-Cubas I; Villagrasa JR; Serra López-Matencio JM; Ancochea J; Urzainqui A; Esparcia-Pinedo L; Alfranca A; de la Fuente H; García-Vicuña R; Sánchez-Madrid F; González-Álvaro I; Castañeda S.
NPJ Vaccines
(Unknown)
Published: 2024
MVA-based vaccine candidates encoding the native or prefusion-stabilized SARS-CoV-2 spike reveal differential immunogen…
Mayer L; Weskamm LM; Fathi A; Kono M; Heidepriem J; Krähling V; Mellinghoff SC; Ly ML; Friedrich M; Hardtke S; Borregaard S; Hesterkamp T; Loeffler FF; Volz A; Sutter G; Becker S; Dahlke C; Addo MM.
NPJ Vaccines
(Unknown)
Published: 2024
Three immunizations with Novavax's protein vaccines increase antibody breadth and provide durable protection from SARS-…
Lenart K; Arcoverde Cerveira R; Hellgren F; Ols S; Sheward DJ; Kim C; Cagigi A; Gagne M; Davis B; Germosen D; Roy V; Alter G; Letscher H; Van Wassenhove J; Gros W; Gallouët AS; Le Grand R; Kleanthous H; Guebre-Xabier M; Murrell B; Patel N; Glenn G; Smith G; Loré K.
NPJ Vaccines
(Unknown)
Published: 2024
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Martinez FJ; White M; Guillotte-Blisnick M; Huon C; Boucharlat A; Agou F; England P; Popovici J; Hou MM; Silk SE; Barrett JR; Nielsen CM; Reimer JM; Mukherjee P; Chauhan VS; Minassian AM; Draper SJ; Chitnis CE.
NPJ Vaccines
(Unknown)
Published: 2024
Absolute quantitation of binding antibodies from clinical samples.
Tang C; Verwilligen A; Sadoff J; Brandenburg B; Sneekes-Vriese E; van den Kerkhof T; Dillen L; Rutten L; Juraszek J; Callewaert K; Janssen S; Huizingh J; Euler Z; Schilperoord T; Verhemeldonck M; Langedijk JPM; Hendriks J; Stieh DJ.
NPJ Vaccines
(Unknown)
Published: 2024
Antigen self-anchoring onto bacteriophage T5 capsid-like particles for vaccine design.
Vernhes E; Larbi Chérif L; Ducrot N; Vanbergue C; Ouldali M; Zig L; Sidibe N; Hoos S; Ramirez-Chamorro L; Renouard M; Rossier O; England P; Schoehn G; Boulanger P; Benihoud K.
NPJ Vaccines
(Unknown)
Published: 2024